The pumpers are wetting themselves because one of them found a picture of something like an actipatch on the Electrome website a couple of weeks ago.
Yes, Electrome is supposed to be the secret NDA partner.
Electrome is only 7 months old. They can't fund THEMSELVES yet, let alone a train wreck like BIEL. They can't even decide on their name -- it's either Electrome or "Electro Therapeutics."
Just in case any of the pumpers want to utter the phrase "reverse merger" -- just don't. BIEL is the WORST reverse merger candidate you could possibly find. Shells with no debt, drastically better share structures, and multi-million-dollar NOLs are readily available. More importantly: Ken Mayer is the kind of CEO who would do an IPO instead of a RM just for the added funding, IMO.
I see why Hawk didn't want to reveal their identity. Electrome needs money, not a boat anchor like BIEL around their neck. I can imagine Ken Mayer's enthusiasm when he first found the ActiPatch on the web, followed by the slow realization of the truth as he did his DD.
The volume today wasn't from Electrome -- it was from the PR because "this is a news driven stock!" Some biotech traders tried to run it up the flagpole, but nobody saluted. The manipulators were the only buyers and now they'll have to dump it .00015 or .0001 because they're not going to get their .0002 back.
Welcome to the party, fellas.
BIEL
Market Data 
Markets 
AI
